Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Conditions
- Astrocytoma, IDH-Mutant, Grade 3
Interventions
- RADIATION: Intensity-Modulated Radiation Therapy
- RADIATION: Volume Modulated Arc Therapy
- RADIATION: Pencil Beam Scanning
- PROCEDURE: Intensity-Modulated Proton Therapy
- DRUG: Temozolomide
- DRUG: Vorasidenib
- DRUG: Placebo Administration
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Magnetic Resonance Imaging
- OTHER: Questionnaire Administration
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators